1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74. 2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. 3. Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Survival rate estimation and its associated factors in patients with Gastric Cancer in Tohid Hospital in Sanandaj. Sci J Kurdistan Univ Med Sci. 2013;18(2):1-8. 4. Etemad K,Gooya MM. National report on registered cancer cases in 2009. Tehran, Iran: Cancer Office,Centre for Disease Control, Deputy for Health, Ministry of Health and Medical Education:2009(persian). 5. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A,Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107: 113 – 118 6. Adami H-O, Hunter D, Tricoploulos D. Textbook of cancer epidemiology.2002. 162-87 p. 7. Gunderson LL, Sosin H. Adenocarcinoma of the stomach-areas of failure in a reoperation series(second or symptomatic looks): Clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:1-11. 8. Ahmadloo N, Omidvari SH, Mosalaei A. [Results of post-operative radiotherapy in patients with high risk gastric cancer]. Med Res J 2003;1(2): 43-49. (Persian) 9. Biglarian A, Hajizadeh E, Gohari M, Khodabakhshi R. [Survival analysis of gastric cancer patients and its risk factors:a five year study]. Kosar Med J. 2007; 12(4): 345-355.(Persian) 10. Yazdanband A, Samadi F, Malekzadeh R, Babaei M, Iranparvar M, Aezami A. [Four years Survival rates of patients with upper gastrointes 11. Matsuda T, Saika K. The 5-year relative survival rate of stomach cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2013 Nov;43(11):1157-8. doi: 10.1093/jjco/hyt166. 12. Moradi G, Karimi K, Esmailnasab N, Roshani D. Survival of Patients with Stomach Cancer and its Determinants in Kurdistan. Asian Pac J Cancer Prev. 2016;17(7):3243-8. PMID: 27509957. 13. Khedmat H, Amini M, Ghamar-Chehreh ME, Hadi R, Taheri S. Unfavorable survival rates in Iranian patients with gastric cancers: a single center experience from Tehran. Acta Med Iran. 2014;52(3):210-4. 14. Anderson L, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin A, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5. Eur J5. Eur J Cancer. 2015; 51(15):2144-57. 15. Baeradeh N, Lotfi M, Fallahzadeh H, Kargar S, Salman Roghani H. Survival rate of patients with Gastric Cancer and its effective factors in Yazd Province. J Community Health Res. 2015; 3:278-87. 16. Akhondzadeh E, Yavari P, Mehrabi Y, Kabir A. Estimates of One, Three, and Five Year Survival Rate of Patients with Gastric Cancer in Iran Using the Meta-Analysis Method. Iran J Epidemiol. 2015;11(1):112. [Persian] 17. Mehrabian A, Esna-Ashari F, Zham H, Hadizadeh M, Bohlooli M, Khayamzadeh M, et al. Gastric cancer prevalence, according to survival data in Iran (National Study-2007). Iran J Public Health. 2010;39(3):27-31. [Persian] 18. Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen S, et al. The survival and the longterm trends of patients with gastric cancer in Shanghai, China. BMC cancer. 2014;14(1):300-312. 19. Moghimi Dehkordi B, Rajaeefard A, Tabatabaee H, Zeighami B, Safaee A, Tabeie Z. Modeling survival analysis in gastric cancer patients using the proportional hazards model of Cox. Iran J Epidemiol. 2007;3(1):19-24. [Persian] 20. Mita K, Ito H, Katsube T, Tsuboi A, Yamazaki N, Asakawa H, Hayashi T, Fujino K. Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer. J Gastrointest Surg. 2017; 21(12):1993-1999. 21. Sun F, Sun H, Mo X, Tang J, Liao Y, Wang S, Su Y, Ma H. Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: A period analysis from 1984 to 2013. J Gastroenterol Hepatol. 2018;33(4):837-846. 22. Tokunaga M, Ito S, Yoshikawa T, Nunobe S, Fukagawa T, Misawa K, Cho H, Katai H, Sano T, Terashima M. Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan. Br J Surg. 2017; 104(7):885-890. 23. Roshanaei GH, Kazemnezhad A, Sadighi S. Estimation of Survival in Patients with Gastric Cancer Surgery at Imam Khomeini Cancer Institute, Tehran, Iran. Third Univ Zadan Zadan Med Serv. Period, number 3, year 1389- machine gun number 57. 24. Borfeei F, Abbasi khodabakhshi G. Survival Estimation and Determination of Survival Related Factors in Patients with Adenocarcinoma of Gastric Cancer in Shahid Fayazbakhsh Hospital, Tehran. Razi J Med Sci. Volume 21, Issue 123 September 2013. 25. Zendedel K, Marzban M, Jafari N, Nahvi jovei A, Mohagheghi MA. Geographical pattern of mortality rates and epidemiology of gastric cancer in Iran. J Knowl Health. Summer 2010, Volume 5, Issue of 6th Iranian Congress of Epidemiology. 26. Paknazar F, Mahmoudi M, Mohammad K, Zeraati H, Mansournia MA, Yaseri M. Estimating the Net Survival of Patients with Gastric Cancer in Iran in a Relative Survival Framework. Iran J Med Sci. 2018;43(6):605. 27. Orman S, Cayci HM. Gastric cancer: factors affecting survival. Acta Chir Belg. 2018;1-7.DOI: 10.1080/00015458.2018.1453437.
|